Telomerase-based Cancer Therapeutics: A Review on their Clinical Trials
Nicola Relitti(University of Siena), Giuseppe Campiani(University of Siena), Stefania Butini(University of Siena), Simone Brogi(University of Pisa), Stefano Federico(University of Siena), Margherita Brindisi(University of Naples Federico II), Sandra Gemma(University of Siena), A. Prasanth Saraswati(University of Siena), Tuhina Khan(University of Siena), Daniela M. Zisterer(Trinity College Dublin)
Cited by 54
Related Papers
Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance
|Current Medicinal Chemistry|2017|127
Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions
|European Journal of Medicinal Chemistry|2017|119
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases
|Journal of Medicinal Chemistry|2019|115